Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9 Ameliorates Liver Fibrosis via Mitigation of Intestinal Endotoxemia

Overview of attention for article published in Inflammation, November 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,523 followers.

Inhibition of proprotein convertase subtilisin/kexin type 9 ameliorates #LiverFibrosis via mitigation of intestinal endotoxemia. https://t.co/rhzN2JeDF8

12 Dec 2019

Reply Repost Favourite

Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9 Ameliorates Liver Fibrosis via Mitigation of Intestinal Endotoxemia. https://t.co/R7fk5iNV2w

30 Nov 2019

Reply Repost Favourite

Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9 Ameliorates Liver Fibrosis via Mitigation of Intestinal Endotoxemia. https://t.co/T0G5lM3Fpy

30 Nov 2019

Reply Repost Favourite